awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38932150-56AE0099-B9C8-43FD-B309-388017A5BBD1
Q38932150-56AE0099-B9C8-43FD-B309-388017A5BBD1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38932150-56AE0099-B9C8-43FD-B309-388017A5BBD1
Biosimilars and the extrapolation of indications for inflammatory conditions.
P2860
Q38932150-56AE0099-B9C8-43FD-B309-388017A5BBD1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38932150-56AE0099-B9C8-43FD-B309-388017A5BBD1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9270bb7ae4bc7c42f3b42b101ec3f8b0e001fa1c
P2860
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.